Receptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva)

Pharmacology Biochemistry and Behavior

Volumn 94, Issue 1, 2009, Pages 211-218

  Ray, Andrew P ^a   Chebolu, Seetha ^a   Darmani, Nissar A ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Cisplatin; Dopamine; Dorsal raphe nucleus; Dorsal vagal complex; Myenteric plexus; Paraventricular thalamic nucleus; Serotonin; Submucosal plexus; Substance P; Vomiting

Indexed keywords

2 METHYLSEROTONIN; 5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; CISPLATIN; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE 3 RECEPTOR STIMULATING AGENT; NEUROTRANSMITTER; PROTEIN FOS; QUINELORANE; QUINPIROLE; SEROTONIN 3 AGONIST; TACHYKININ RECEPTOR AGONIST;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NUCLEUS; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; FEMALE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE INNERVATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHREW; SOLITARY TRACT NUCLEUS; THALAMUS NUCLEUS; VAGUS NERVE DORSAL NUCLEUS; VOMITING;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; BRAIN; BRAIN STEM; EMETICS; ENTERIC NERVOUS SYSTEM; FEMALE; INJECTIONS, INTRAPERITONEAL; NEURONS; PERFUSION; PROTO-ONCOGENE PROTEINS C-FOS; SEROTONIN; SHREWS; SOLITARY NUCLEUS; SUBSTANCE P; TIME FACTORS; VAGUS NERVE; VOMITING;

CRYPTOTIS PARVA; MAMMALIA;

EID: 70349226642     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.08.010     Document Type: Article

References (78)

1. Andrews P.L. Physiology of nausea and vomiting. Br J Anaesth 69 (1992) 2S-19S
2. Arluison M., and Derer P. Forebrain connections of the rat paraventricular thalamic nucleus as demonstrated using the carbocyanide dye DiI. Neurobiology (Bp) 1 (1993) 337-350
3. Berthoud H.R., Patterson L.M., and Zheng H. Vagal-enteric interface: vagal activation-induced expression of c-Fos and p-CREB in neurons of the upper gastrointestinal tract and pancreas. Anat Rec 262 (2001) 29-40
4. Bhandari P., Bingham S., and Andrews P.L. The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacology 31 (1992) 735-742
5. Boissonade F.M., Davison J.S., Egizii R., Lucier G.E., and Sharkey K.A. The dorsal vagal complex of the ferret: anatomical and immunohistochemical studies. Neurogastroenterol Motil 8 (1996) 255-272
6. Boissonade F.M., Sharkey K.A., and Davison J.S. Fos expression in ferret dorsal vagal complex after peripheral emetic stimuli. Am J Physiol 266 (1994) R1118-R1126
7. Bubser M., and Deutch A.Y. Thalamic paraventricular nucleus neurons collateralize to innervate the prefrontal cortex and nucleus accumbens. Brain Res 787 (1998) 304-310
8. Bureau Y., Handa M., Zhu Y., Laliberte F., Moore C.S., and Liu S. Neuroanatomical and pharmacological assessment of Fos expression induced in the rat brain by the phosphodiesterase-4 inhibitor 6-(4-pyridylmethyl)-8-(3-nitrophenyl) quinoline. Neuropharmacology 51 (2006) 974-985
9. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
10. Commons K.G., and Valentino R.J. Cellular basis for the effects of substance P in the periaqueductal gray and dorsal raphe nucleus. J Comp Neurol 447 (2002) 82-97
11. Conley R.K., Cumberbatch M.J., Mason G.S., Williamson D.J., Harrison T., Locker K., et al. (neurokinin 1) receptor antagonists enhance dorsal raphe neuronal activity. J Neurosci 22 (2002) 7730-7736
12. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., and Malave J.J. Changes in serotonin metabolism in cancer patients: its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 66 (1992) 198-203
13. Darmani N.A. Endocannabinoids and gastrointestinal function. In: Onaivi E.S., Sugiura T., and Di Marzo V. (Eds). The Brain and Body's Marijuana and Beyond (2005), CRC, Boca Raton 393-418
14. Darmani N.A. The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. J Pharmacol Exp Ther 300 (2002) 34-42
15. Darmani N.A. Serotonin 5-HT3 receptor antagonists prevent cisplatin-induced emesis in Cryptotis parva: a new experimental model of emesis. J Neural Transm 105 (1998) 1143-1154
16. Darmani N.A., and Crim J.L. Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva). Pharmacol Biochem Behav 80 (2005) 35-44
17. Darmani N.A., Crim J.L., Janoyan J.J., Abad J., and Ramirez J. A re-evaluation of the neurotransmitter basis of chemotherapy-induced immediate and delayed vomiting: evidence from the least shrew. Brain Res 1248 (2009) 40-58
18. Darmani N.A., and Johnson J.C. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis. Eur J Pharmacol 488 (2004) 201-212
19. Darmani N.A., McClanahan B.A., Trinh C., Petrosino S., Valenti M., and Di Marzo V. Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew. Neuropharmacology 49 (2005) 502-513
20. Darmani N.A., and Ray A.P. Evidence for a re-evaluation of the neurochemical and anatomical bases of chemotherapy-induced vomiting. Chem Rev 109 (2009) 3158-3199
21. Darmani N.A., Wang Y., Abad J., Ray A.P., Thrush G.R., and Ramirez J. Utilization of the least shrew as a rapid and selective screening model for the antiemetic potential and brain penetration of substance P and NK(1) receptor antagonists. Brain Res 1214 (2008) 58-72
22. Darmani N.A., Zhao W., and Ahmad B. The role of D2 and D3 dopamine receptors in the mediation of emesis in Cryptotis parva (the least shrew). J Neural Transm 106 (1999) 1045-1061
23. Davis S.F., Derbenev A.V., Williams K.W., Glatzer N.R., and Smith B.N. Excitatory and inhibitory local circuit input to the rat dorsal motor nucleus of the vagus originating from the nucleus tractus solitarius. Brain Res 1017 (2004) 208-217
24. Dragunow M., and Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J Neurosci Methods 29 (1989) 261-265
25. Dragunow M., and Robertson H.A. Localization and induction of c-fos protein-like immunoreactive material in the nuclei of adult mammalian neurons. Brain Res 440 (1988) 252-260
26. du Bois A., Vach W., Siebert C., Holy R., Ledergerber M., Wechsel U., and Kriesinger-Schroeder H. The relationship between parameters of serotonin metabolism and emetogenic potential of platinum-based chemotherapy regimens. Support Care Cancer 5 (1997) 212-218
27. Endo T., Minami M., Hirafuji M., Ogawa T., Akita K., Nemoto M., et al. Neurochemistry and neuropharmacology of emesis - the role of serotonin. Toxicology 153 (2000) 189-201
28. Fukuda H., and Koga T. Non-respiratory neurons in the Botzinger complex exhibiting appropriate firing patterns to generate the emetic act in dogs. Neurosci Res 14 (1992) 180-194
29. Fukuda H., Koga T., Furukawa N., Nakamura E., and Shiroshita Y. The tachykinin NK1 receptor antagonist GR205171 abolishes the retching activity of neurons comprising the central pattern generator for vomiting in dogs. Neurosci Res 33 (1999) 25-32
30. Fukui H., Yamamoto M., Ando T., Sasaki S., and Sato S. Increase in serotonin levels in the dog ileum and blood by cisplatin as measured by microdialysis. Neuropharmacology 32 (1993) 959-968
31. Guiard B.P., Guilloux J.P., Reperant C., Hunt S.P., Toth M., Gardier AM.S., et al. Neurokinin 1 receptor activation within the dorsal raphe nucleus controls serotonin release in the mouse frontal cortex. Mol Pharmacol 72 (2007) 1411-1418
32. Hawthorn J., Ostler K.J., and Andrews P.L. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Q J Exp Physiol 73 (1988) 7-21
33. Hesketh P.J., Van Belle S., Aapro M., Tattersall F.D., Naylor R.J., Hargreaves R., et al. Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists. Eur J Cancer 39 (2003) 1074-1080
34. Higa G.M., Auber M.L., Altaha R., Piktel D., Kurian S., Hobbs G., et al. 5-Hydroxyindoleacetic acid and substance P profiles in patients receiving emetogenic chemotherapy. J Oncol Pharm Pract 12 (2006) 201-209
35. Higgins G.A., Kilpatrick G.J., Bunce K.T., Jones B.J., and Tyers M.B. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol 97 (1989) 247-255
36. Horn C.C., Ciucci M., and Chaudhury A. Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness. Auton Neurosci 148 (2006) 76-82
37. Hornby P.J. Central neurocircuitry associated with emesis. Am J Med 111 Suppl 8A (2001) 106S-112S
38. Hornby P.J., and Abrahams T.P. Central control of lower esophageal sphincter relaxation. Am J Med 108 Suppl 4a (2000) 90S-98S
39. Hunt S.P., Pini A., and Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 328 (1987) 632-634
40. Hyde T.M., Knable M.B., and Murray A.M. Distribution of dopamine D1-D4 receptor subtypes in human dorsal vagal complex. Synapse 24 (1996) 224-232
41. Ito H., Nishibayashi M., Kawabata K., Maeda S., Seki M., and Ebukuro S. Immunohistochemical demonstration of c-fos protein in neurons of the medulla oblongata of the musk shrew (Suncus murinus) after veratrine administration. Exp Anim 51 (2002) 19-25
42. Ito H., Nishibayashi M., Kawabata K., Maeda S., Seki M., and Ebukuro S. Induction of Fos protein in neurons in the medulla oblongata after motion- and X-irradiation-induced emesis in musk shrews (Suncus murinus). Auton Neurosci 107 (2003) 1-8
43. Johnson K.B., Criswell H.E., Jensen K.F., Simson P.E., Mueller R.A., and Breese G.R. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity. J Pharmacol Exp Ther 262 (1992) 855-865
44. Kan K.K., Jones R.L., Ngan M.P., and Rudd J.A. Actions of prostanoids to induce emesis and defecation in the ferret. Eur J Pharmacol 453 (2002) 299-308
45. Kirchgessner A.L., Tamir H., and Gershon M.D. Identification and stimulation by serotonin of intrinsic sensory neurons of the submucosal plexus of the guinea pig gut: activity-induced expression of Fos immunoreactivity. J Neurosci 12 (1992) 235-248
46. Koga T., and Fukuda H. Neurons in the nucleus of the solitary tract mediating inputs from emetic vagal afferents and the area postrema to the pattern generator for the emetic act in dogs. Neurosci Res 14 (1992) 166-179
47. Koga T., Qu R., and Fukuda H. The central pattern generator for vomiting may exist in the reticular area dorsomedial to the retrofacial nucleus in dogs. Exp Brain Res 118 (1998) 139-147
48. Krowicki Z.K., and Hornby P.J. Substance P in the dorsal motor nucleus of the vagus evokes gastric motor inhibition via neurokinin 1 receptor in rat. J Pharmacol Exp Ther 293 (2000) 214-221
49. Miller A.D., and Nonaka S. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J Pharmacol Exp Ther 260 (1992) 509-517
50. Miller A.D., Nonaka S., and Jakus J. Brain areas essential or non-essential for emesis. Brain Res 647 (1994) 255-264
51. Miller A.D., and Ruggiero D.A. Emetic reflex arc revealed by expression of the immediate-early gene c-fos in the cat. J Neurosci 14 (1994) 871-888
52. Minami M., Endo T., Hirafuji M., Hamaue N., Liu Y., Hiroshige T., et al. Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity. Pharmacol Ther 99 (2003) 149-165
53. Moga M.M., Weis R.P., and Moore R.Y. Efferent projections of the paraventricular thalamic nucleus in the rat. J Comp Neurol 359 (1995) 221-238
54. Morgan J.I., and Curran T. Calcium and proto-oncogene involvement in the immediate-early response in the nervous system. Ann N Y Acad Sci 568 (1989) 283-290
55. Onishi T., Mori T., Yanagihara M., Furukawa N., and Fukuda H. Similarities of the neuronal circuit for the induction of fictive vomiting between ferrets and dogs. Auton Neurosci 136 (2007) 20-30
56. Ray A.P., and Darmani N.A. A histologically derived stereotaxic atlas and substance P immunohistochemistry in the brain of the least shrew (Cryptotis parva) support its role as a model organism for behavioral and pharmacological research. Brain Res 1156 (2007) 99-111
57. Ray A.P., Griggs L., and Darmani N.A. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew. Behav Brain Res 196 (2009) 30-36
58. Reynolds D.J., Barber N.A., Grahame-Smith D.G., and Leslie R.A. Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694). Brain Res 565 (1991) 231-236
59. Ricardo J.A., and Koh E.T. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdala, and other forebrain structures in the rat. Brain Res 153 (1978) 1-26
60. Sagar S.M., Sharp F.R., and Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240 (1988) 1328-1331
61. Sam T.S., Cheng J.T., Johnston K.D., Kan K.K., Ngan M.P., Rudd J.A., et al. Action of 5-HT3 antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur J Pharmacol (2003) 135-145
62. Sharkey K.A., Cristino L., Oland L.D., Van Sickle M.D., Starowicz K., Pittman Q.J., et al. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci 25 (2007) 2773-2782
63. Simoneau I.I., Hamza M.S., Mata H.P., Siegel E.M., Vanderah T.W., Porreca F., et al. The cannabinoid agonist WIN55, 212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94 (2001) 882-887
64. Szelenyi I., Herold H., and Gothert M. Emesis induced in domestic pigs: a new experimental tool for detection of antiemetic drugs and for evaluation of emetogenic potential of new anticancer agents. J Pharmacol Toxicol Methods 32 (1994) 109-116
65. Tanihata S., Oda S., Nakai S., and Uchiyama T. Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon. Eur J Pharmacol 484 (2004) 311-321
66. Thompson S.M., and Robertson R.T. Organization of subcortical pathways for sensory projections to the limbic cortex. I. Subcortical projections to the medial limbic cortex in the rat. J Comp Neurol 265 (1987) 175-188
67. Thor K.B., and Helke C.J. Serotonin- and substance P-containing projections to the nucleus tractus solitarii of the rat. J Comp Neurol 265 (1987) 275-293
68. Travagli R.A., Hermann G.E., Browning K.N., and Rogers R.C. Brainstem circuits regulating gastric function. Annu Rev Physiol 68 (2006) 279-305
69. Valentino R.J., Bey V., Pernar L., and Commons K.G. Substance P Acts through local circuits within the rat dorsal raphe nucleus to alter serotonergic neuronal activity. J Neurosci 23 (2003) 7155-7159
70. Van Sickle M.D., Oland L.D., Mackie K., Davison J.S., and Sharkey K.A. Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets. Am J Physiol Gastrointest Liver Physiol 285 (2003) G566-G576
71. Veyrat-Follet C., Farinotti R., and Palmer J.L. Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds. Drugs 53 (1997) 206-234
72. Wang S.C., and Borison H.L. A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides. Gastroenterology 22 (1952) 1-12
73. Watson J.W., Gonsalves S.F., Fossa A.A., McLean S., Seeger T., Obach S., et al. The anti-emetic effects of CP-99, 994 in the ferret and the dog: role of the NK1 receptor. Br J Pharmacol 115 (1995) 84-94
74. Xiong W., Hosoi M., Koo B., and Zhang L. Anandamide inhibition of 5-HT3A receptors varies with receptor density and desensitization. Mol Pharmacol 73 (2008) 314-322
75. Yip J., and Chahl L.A. Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [SAR9, MET(O2)11]substance P. Neuroscience 94 (1999) 663-673
76. Yip J., and Chahl L.A. Localization of NK1 and NK3 receptors in guinea-pig brain. Regul Pept 98 (2001) 55-62
77. Yoshikawa T., Yoshida N., and Hosoki K. Involvement of dopamine D3 receptors in the area postrema in R(+)-7-OH-DPAT-induced emesis in the ferret. Eur J Pharmacol 301 (1996) 143-149
78. Zaman S., Woods A.J., Watson J.W., Reynolds D.J., and Andrews P.L. The effect of the NK1 receptor antagonist CP-99, 994 on emesis and c-fos protein induction by loperamide in the ferret. Neuropharmacology 39 (2000) 316-323